Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on May 14, 2009

Stroke. 2009
Published online before print May 14, 2009, doi: 10.1161/STROKEAHA.109.548974
A more recent version of this article appeared on July 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/7/2382    most recent
STROKEAHA.109.548974v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenberg, S. M.
Right arrow Articles by Smith, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenberg, S. M.
Right arrow Articles by Smith, E. E.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Amyloidosis
Related Collections
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Intracerebral Hemorrhage
Right arrow Pathology of Stroke

Submitted on January 27, 2009
Accepted on February 12, 2009

Microbleeds Versus Macrobleeds. Evidence for Distinct Entities

Steven M. Greenberg MD, PhD*; R. N. Kaveer Nandigam MD; Pilar Delgado MD, PhD; Rebecca A. Betensky PhD; Jonathan Rosand MD, MSc; Anand Viswanathan MD, PhD; Matthew P. Frosch MD, PhD; and Eric E. Smith MD, MPH

From the Hemorrhagic Stroke Research Program (S.M.G., R.N.K.N., P.D., J.R., A.V., E.E.S.), Department of Neurology, and the C.S. Kubik Laboratory in Neuropathology (M.P.F.), Massachusetts General Hospital and Harvard Medical School, Boston, Mass; and the Department of Biostatistics (R.A.B.), Harvard School of Public Health, Boston, Mass.

* To whom correspondence should be addressed. E-mail: sgreenberg{at}partners.org.

Background and Purpose—Small, asymptomatic microbleeds commonly accompany larger symptomatic macrobleeds. It is unclear whether microbleeds and macrobleeds represent arbitrary categories within a single continuum versus truly distinct events with separate pathophysiologies.

Methods—We performed 2 complementary retrospective analyses. In a radiographic analysis, we measured and plotted the volumes of all hemorrhagic lesions detected by gradient-echo MRI among 46 consecutive patients with symptomatic primary lobar intracerebral hemorrhage diagnosed as probable or possible cerebral amyloid angiopathy. In a second neuropathologic analysis, we performed blinded qualitative and quantitative examinations of amyloid-positive vessel segments in 6 autopsied subjects whose MRI scans demonstrated particularly high microbleed counts (>50 microbleeds on MRI, n=3) or low microbleed counts (<3 microbleeds, n=3).

Results—Plotted on a logarithmic scale, the volumes of 163 hemorrhagic lesions identified on scans from the 46 subjects fell in a distinctly bimodal distribution with mean volumes for the 2 modes of 0.009 cm3 and 27.5 cm3. The optimal cut point for separating the 2 peaks (determined by receiver operating characteristics) corresponded to a lesion diameter of 0.57 cm. On neuropathologic analysis, the high microbleed-count autopsied subjects showed significantly thicker amyloid-positive vessel walls than the low microbleed-count subjects (proportional wall thickness 0.53±0.01 versus 0.37±0.01; P<0.0001; n=333 vessel segments analyzed).

Conclusions—These findings suggest that cerebral amyloid angiopathy-associated microbleeds and macrobleeds comprise distinct entities. Increased vessel wall thickness may predispose to formation of microbleeds relative to macrobleeds.


Key words: cerebral amyloid angiopathy • intracerebral hemorrhage • microbleeds